je.st
news
Mallinckrodt buying Cadence Pharmaceuticals for approximately $1.21 billion
2014-02-11 17:48:35| Biotech - Topix.net
The health care products company Mallinckrodt is buying Cadence Pharmaceuticals for about $1.21 billion in a bid to strengthen its specialty drugs unit.
Tags: approximately
buying
billion
pharmaceuticals
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||